A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With
RecruitingNCT06474026Phase: NAStarted 2024-07-01
Summary
The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psych
Eligibility
Sex
ALL
Min Age
19 Years
Max Age
60 Years
Locations
Korea University Anam HospitalSeoul, Seoul, South Korea
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06474026